首页> 外文期刊>Urologia internationalis >Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?
【24h】

Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?

机译:单纯的腹腔镜根治性膀胱切除术仍然是治疗肌肉浸润性膀胱癌的有吸引力的解决方案吗?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of this study is to report our experience with laparoscopic radical cystectomy (LRC), evaluating the technique and perioperative and pathological outcomes. METHODS: 47 LRCs were performed due to muscle-invasive bladder cancer. Conduits were performed in 23 patients and neobladders in 23 (one bi-intestinal). One ureterocutaneostomy was created. RESULTS: In 43 patients LRC was performed with minilaparotomy for urinary diversion. The mean operation time was 290 min. Four operations were converted. Complications included sigmoid colon injury, urinary leak, lymphatic leak, short-term paralytic ileus, and heart attack. Mean blood loss was 220 ml. Hospitalization time was 6 days. Tumor stage was pT2b, pT3a, pT3b, and pT4a in 28, 13, 5, and 1 patient, respectively. No positive margins were found. The mean number of lymph nodules was 17, while in the last 25 procedures it was 21. 17% of patients had tumor in the lymph nodes. The mean follow-up was 10 months. Local recurrence and dissemination was observed in 2%. Continence in patients receiving neobladder was fully satisfactory. CONCLUSIONS: More complications are related to neobladder than to ileac conduit. LRC with minilaparotomy seems to be an attractive treatment option for patients with muscle-invasive bladder cancer. Radical cystectomy performed intracorporeally could be reserved for 'robot-assisted' operations.
机译:目的:本研究的目的是报告我们在腹腔镜根治性膀胱切除术(LRC)方面的经验,评估该技术以及围手术期和病理结果。方法:由于肌肉浸润性膀胱癌,进行了47次LRC。导管在23例患者中进行,新膀胱在23例(一个双肠)中进行。创建了一种输尿管切开皮肤吻合术。结果:在43例患者中,LRC经小切口开腹术进行尿液改道。平均手术时间为290分钟。转换了四个操作。并发症包括乙状结肠损伤,尿漏,淋巴漏,短期麻痹性肠梗阻和心脏病发作。平均失血量为220毫升。住院时间为6天。在28、13、5和1位患者中,肿瘤分期分别为pT2b,pT3a,pT3b和pT4a。未找到正边距。淋巴结平均数目为17,而在最近的25次手术中为21。17%的患者淋巴结中有肿瘤。平均随访时间为10个月。观察到局部复发和传播为2%。接受新膀胱的患者的自控性完全令人满意。结论:与新膀胱有关的并发症多于回肠导管。对于患有肌肉浸润性膀胱癌的患者,微开腹手术的LRC似乎是一种有吸引力的治疗选择。体内进行的根治性膀胱切除术可以保留给“机器人辅助”手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号